Antitumor and anti-cachectic effects of shark liver oil and fish oil: Comparison between independent or associative chronic supplementation in Walker 256 tumor-bearing rats

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Iagher, Fabíola ^a   De Brito Belo, Sérgio Ricardo ^b   Souza, Wanessa Mazanek ^b   Nunes, Juliana Rehlander ^b   Naliwaiko, Katya ^b   Sassaki, Guilherme Lanzi ^b   Bonatto, Sandro José Ribeiro ^b   De Oliveira, Heloísa Helena Paro ^b   Brito, Gleisson Alisson Pereira ^b   De Lima, Carina ^b   Kryczyk, Marcelo ^b   De Souza, Carine Ferreira ^b   Steffani, Jovani Antonio ^a   Nunes, Everson Araújo ^c   Fernandes, Luiz Cláudio ^b  

^a West University of Santa Catarina   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Apoptosis; Cachexia; Cell proliferation; Fish oils; Lipid peroxidation; Rats; Walker 256; Wistar

Indexed keywords

ARACHIDONIC ACID; ECOMER; FISH OIL; GLUCOSE; LACTIC ACID; LAURIC ACID; LINOLEIC ACID; LIPID HYDROPEROXIDE; OIL; OLEIC ACID; PALMITIC ACID; PALMITOLEIC ACID; SHARK LIVER OIL; STEARIC ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTI CACHECTIC EFFECT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CACHEXIA; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; EX VIVO STUDY; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INOCULATION; LACTATE BLOOD LEVEL; LIPID PEROXIDATION; MALE; MASS FRAGMENTOGRAPHY; NONHUMAN; RAT; SUPPLEMENTATION; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; TUMOR CELL; TUMOR GROWTH; TUMOR VOLUME; WALKER CARCINOMA;

CHONDRICHTHYES; RATTUS; RATTUS NORVEGICUS;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CACHEXIA; CARCINOMA 256, WALKER; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIETARY SUPPLEMENTS; FATTY ACIDS; FISH OILS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HYDROGEN PEROXIDE; LIVER; MALE; RATS; RATS, WISTAR; SHARKS; TUMOR BURDEN; WEANING;

EID: 84885438165     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-146     Document Type: Article

References (40)

1. The importance of the ratio of omega-6/omega-3 essential fatty acids. Simopoulos AP, Biomed Pharmacother 2002 56 365 379 10.1016/S0753-3322(02)00253-6 12442909 (Pubitemid 35232740)
2. Novel approaches to the treatment of cachexia. Argilés JM, López-Soriano FJ, Busquets S, Drug Discov Today 2008 13 73 78 10.1016/j.drudis.2007.10.008 18190867
3. Multi-targeted therapy of cancer by omega-3 fatty acids. Berquin IM, Edwards IJ, Chen YQ, Cancer Lett 2008 269 363 377 10.1016/j.canlet.2008.03.044 18479809
4. Mammary tumor development is directly inhibited by lifelong n-3 polyunsaturated fatty acids. MacLennan MB, Clarke SE, Perez K, Wood GA, Muller WJ, Kang JX, Ma DW, J Nutr Biochem 2013 24 388 395 10.1016/j.jnutbio.2012.08.002 23026490
5. Dietary polyunsaturated fatty acids and colorectal neoplasia. McEntee MF, Whelan J, Biomed Pharmacother 2002 56 380 387 10.1016/S0753-3322(02)00254-8 12442910 (Pubitemid 35238055)
6. Ratio of n-6 to n-3 fatty acids in the diet affects tumor growth and cachexia in Walker 256 tumor-bearing rats. Pizato N, Bonatto S, Yamazaki RK, Aikawa J, Nogata C, Mund RC, Nunes EA, Piconcelli M, Naliwaiko K, Curi R, Calder PC, Fernandes LC, Nutr Cancer 2005 53 194 201 10.1207/s15327914nc5302-8 16573380
7. Decreased tumor growth in Walker 256 tumor-bearing rats chronically supplemented with fish oil involves COX-2 and PGE2 reduction associated with apoptosis and increased peroxidation. Mund RC, Pizato N, Bonatto S, Nunes EA, Vicenzi T, Tanhoffer R, Oliveira HH, Curi R, Calder PC, Fernandes LC, Prostaglandins Leukot Essent Fatty Acids 2007 76 113 120 10.1016/j.plefa.2006. 11.008 17234396 (Pubitemid 46217230)
8. Mediators involved in the cancer anorexia-cachexia syndrome: past, present and future. Argilés JM, Busquets S, García-Martinez C, López-Soriano FJ, Nutrition 2005 21 977 985 10.1016/j.nut.2005.02.003 16043325 (Pubitemid 41188098)
9. Fish oil and treatment of cancer cachexia. Giacosa A, Rondanelli M, Genes Nutr 2008 3 25 28 10.1007/s12263-008-0078-1 18850196
10. Effect of fish oil supplementation for 2 generations on changes in macrophage function induced by Walker 256 cancer cachexia in rats. Folador A, Hirabara SM, Bonatto SJR, Aikawa J, Yamazaki RK, Curi R, Fernandes LC, Int J Cancer 2006 120 344 350 (Pubitemid 44956844)
11. Effect of altering dietary ω-6/ω-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. Kobayashi N, Barnard RJ, Henning SM, Elashoff D, Reddy ST, Cohen P, Leung P, Hong-Gonzalez J, Freedland SJ, Said J, Gui D, Seeram NP, Popoviciu LM, Bagga D, Heber D, Glaspy JA, Aronson WJ, Clin Cancer Res 2006 12 4662 4670 10.1158/1078-0432.CCR-06-0459 16899616 (Pubitemid 44297819)
12. A high ratio of dietary n-6/n-3 polyunsaturated fatty acids is associated with increased risk of prostate cancer. Williams CD, Whitley BM, Hoyo C, Gant DJ, Iraggi JD, Newman KA, Gerber L, Taylor LA, McKeever MG, Freedland SJ, Nutr Res 2011 31 1 8 10.1016/j.nutres.2011.01.002 21310299
13. N-3 polyunsaturaed fatty acids and inflammation: from molecular biology to the clinic. Calder PC, Lipids 2003 38 342 352
14. Fish oil suppress angiogenesis, reduces cell proliferation and DNA damage in rat mammary carcinogenesis. Manna S, Das S, Roy K, Rana A, Chatterjee M, ESPEN J 2012 7 86 e92
15. The effects of fish oil, olive oil, oleic acid and linoleic acid on colorectal neoplastic processes. Llor X, Pons E, Roca A, Alvarez M, Mañé J, Fernández-Bañares F, Gassull MA, Clin Nutr 2003 22 71 79 10.1054/clnu.2002.0627 12553953 (Pubitemid 36193183)
16. Lipid alterations in human colon epithelial cells induced to differentiation and/or apoptosis by butyrate and polyunsaturated fatty acids. Hofmanová J, Ciganek M, Slavík J, Kozubík A, Stixová L, Vacolová A, Dusek L, Machala M, J Nutr Biochem 2012 23 539 548 10.1016/j.jnutbio.2011.02.010 21775115
17. Regression of tumour growth after administration of alkoxyglycerols. Brohult A, Brohult J, Brohult S, Acta Obstet Gynecol Scand 1978 57 79 83 10.3109/00016347809154203 622894 (Pubitemid 8265693)
18. Natural 1-O-alkylglycerols reduced platelet-activating factor-induced released of [§ssup§3§esup§H]-serotonin in rabbit platelets. Pedrono F, Cheminade C, Legrand AB, Prostaglandins Leucot Essent Fatty Acids 2004 71 19 23 10.1016/j.plefa.2003.12.003 (Pubitemid 38881241)
19. Enhancement of antibody production by lysophosphatidylcholine and alkylglycerol. Ngwenya BZ, Foster DM, Proc Soc Exp Biol Med 1991 196 69 75 10.3181/00379727-196-43165 1984244
20. Modulation of endothelial permeability by 1-O-alkylglycerols. Marigny K, Pedrono F, Martin-Chouly CAE, Youmine H, Saiag B, Legrand AB, Acta Physiol Scand 2002 176 263 10.1046/j.1365-201X.2002.01037.x 12444931 (Pubitemid 35417379)
21. Effect of alkoxyglycerols on the frequency of injuries following radiation therapy for carcinoma of the uterine cervix. Brohult A, Brohult J, Brohult S, Joelsson I, Acta Obstet Gynecol Scand 1977 56 441 448 10.3109/00016347709155008 602713 (Pubitemid 8248945)
22. Walker-256 tumor growth is inhibited by the independent or associative chronic ingestion of shark liver and fish oil: a response linked by the increment of peritoneal macrophages nitrite production in Wistar rats. Belo SRB, Iagher F, Bonatto SJ, Naliwaiko K, Calder PC, Nunes EA, Fernandes LC, Nutr Res 2010 30 770 776 10.1016/j.nutres.2010.09.015 21130296
23. Chronic Supplementation With Shark Liver Oil for Reducing Tumor Growth and Cachexia in Walker 256 Tumor-Bearing Rats. Iagher F, Belo SRB, Naliwaiko K, Franzói AM, Brito GAP, Yamazaki RK, Muritiba AL, Muehlmann LA, Steffani JA, Fernandes LC, Nutr Cancer 2011 63 1307 1315 10.1080/01635581.2011.607540 21981555
24. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Donaldson MS, Nutr J 2004 3 19 10.1186/1475-2891-3-19 15496224 (Pubitemid 39532850)
25. Fish oil supplementation in F1 generation associated with naproxen, clenbuterol, and insulin administration reduce tumor growth and cachexia in Walker 256 tumor-bearing rats. Pinto JA Jr, Folador A, Bonatto SJ, Aikawa J, Yamazaki RK, Pizato N, Facin M, Grohs H, Oliveira HHP, Naliwaiko K, Ferraz AC, Nishiyama A, Fernandez R, Curi R, Fernandes LC, J Nutr Biochem 2004 15 358 365 10.1016/j.jnutbio.2004.02.002 15157942 (Pubitemid 38639867)
26. Alkyl analogs of diacylglycerol as activators of protein kinase C. Heymans F, Da Silva C, Marrec N, Godfroid JJ, Castagna M, FEBS Lett 1987 218 35 40 10.1016/0014-5793(87)81013-X 3595862
27. Protein kinase C and other diacylglycerol effectors in cancer. Griner EM, Kazanietz MG, Nat Rev Cancer 2007 7 281 294 10.1038/nrc2110 17384583 (Pubitemid 46480971)
28. Which alkylglycerols from shark liver oil have anti-tumor activities? Deniau AL, Mosset P, Le Bot D, Legrand AB, Biochimie 2011 93 1 3 10.1016/j.biochi.2009.12.010 20036307
29. Effect of anti-tumor ether lipids on ordered domains in model membranes. Heczková B, Slotte JP, FEBS Lett 2006 580 2471 2476 10.1016/j.febslet. 2006.03.079 16638573
30. Identification of novel autoxidation products of the ω-3 fatty acid eicosapentaenoic acid in vitro and in vivo. Yin H, Brooks JD, Gao L, Porter NA, Morrow JD, J Biol Chem 2007 282 29890 29901 10.1074/jbc.M703108200 17711863 (Pubitemid 350035269)
31. Effects of polyunsaturated fatty acids on the growth of gastric cancer cells in vitro. Dai J, Shen J, Pan W, Shen S, Das UN, Lipids Health Dis 2013 12 71 10.1186/1476-511X-12-71 23663688
32. Causes an elimination of erratic blanks in enzymatic metabolite assay involving th use of NAD + in alkaline hydrazine buffers: improved conditions for the assay of L-glutamate, L-lactate, and others metabolites. Engle PC, Jones JB, Anal Biochem 1978 88 475 484 10.1016/0003-2697(78)90447-5 29519 (Pubitemid 9061508)
33. Improvement of cancer cachexia and decrease of Walker 256 tumor growth by insulin administration in rats. Fernandes LC, Carpinelli AR, Hell NS, Curi R, Cancer Ther Control 1991 1 259 268
34. A simple method for isolation and purification of total lipid from animal tissue. Folch J, Lees M, Stanley GHS, J Biol Chem 1957 226 497 509 13428781
35. Cancer cachexia and tumor growth reduction in walker 256 tumor-bearing rats supplemented with n-3 polyunsaturated fatty acids for one generation. Togni V, Ota CCC, Folador A, Junior OT, Aikawa J, Yamazaki RK, et al. Nutr Cancer 2003 46 52 58 10.1207/S15327914NC4601-07 12925304 (Pubitemid 37163291)
36. HPLC determination of underivatized fatty acids saponified at 37°C -analysis of fatty acids in oils and tissues. Nishiyama-Naruke A, Souza JA, Carnel M, Curi R, Anal Lett 1998 31 2565 2576 10.1080/00032719808005325 (Pubitemid 28494591)
37. Fatty acids erythrocytes measured by isocratic HPLC. Abushufa R, Reed P, Weinkove C, Clin Chem 1994 40 1707 1712 8070079 (Pubitemid 24273092)
38. Application of acetate derivatives for gas chromatography-mass spectrometry: Novel approaches on carbohydrates, lipids and amino acids analysis. Sassaki GL, Souza LM, Serrato RV, Cipriani TR, Gorin PAJ, Iacomini M, J Chromatogr 2008 1208 215 222 10.1016/j.chroma.2008.08.083
39. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Nourooz-Zadeh J, Tajaddini-Sarmadi J, Wolff SP, Anal Biochem 1994 220 403 409 10.1006/abio.1994.1357 7978285
40. A rapid and sensitive method for the quantitation of microgram quantities utilizing the principle of protein dye binding. Bradford MM, Anal Biochem 1976 72 248 254 10.1016/0003-2697(76)90527-3 942051